Tech Company Financing Transactions
Arcxis Biotechnologies Funding Round
On 8/23/2006, Arcxis Biotechnologies raised $2.3 million in Series A financing from Claremont Creek Ventures.
Transaction Overview
Company Name
Announced On
8/23/2006
Transaction Type
Venture Equity
Amount
$2,250,000
Round
Series A
Investors
Claremont Creek Ventures (John Steuart)
Proceeds Purpose
This first round of institutional investment enables us to hire key employee talent, make certain equipment purchases, and initiate the commercial development programs in our strategic plan.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
6920 Koll Center Pkwy. 215
Pleasanton, CA 94566
USA
Pleasanton, CA 94566
USA
Phone
Website
Email Address
Overview
Arcxis Biotechnologies is focused on developing elegant, integrated and compact solutions to molecular diagnostic challenges.
Management Team
Browse more venture capital transactions:
Prev: 8/23/2006: Kemia venture capital transaction
Next: 8/23/2006: Ablynx venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs